Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 1/2008

01-02-2008

Patient barriers and solutions for INR self-testing

Author: Nancy L. Shapiro

Published in: Journal of Thrombosis and Thrombolysis | Issue 1/2008

Login to get access

Excerpt

Medical technology has improved to allow for more patient empowerment and control of one’s own health care. One such example of this empowerment is in the area of patient INR self-testing. Patient INR self-testing has been shown to improve time in therapeutic range, which can lead to improved clinical outcomes [13]. As promising as this process is for helping to improve the quality of anticoagulation, barriers occur from the patient’s perspective. Results from a survey of 230 anticoagulation clinic providers attending the annual meeting of the Anticoagulation Forum in 2003 were published [4]. Anticoagulation clinic providers identified what they believed were the top three barriers that patients consider for self-testing as the cost of the instrument (86.1%), the cost of the reagent cartridges (72.6%), and lack of knowledge that self-testing is as an option (47.0%). The barrier ranked as number one most frequently by these providers included cost of the instrument (52.6%), lack of knowledge that self-testing is an option (15.2%), and loss of interaction with anticoagulation clinic staff (3.9%). Other problems that can occur with patient self-testing include problems with collection technique, such as not getting a large enough drop of blood, and subsequently wasting strips, as well reliability issues with the patient, including timeliness of getting INR results, failure to report results, and truth of reporting results. …
Literature
1.
go back to reference White RH, McCurdy SA, Von Marensdorff H, Woodruff DE, Leftgoff L (1989) Home prothrombin time monitoring after initiation of warfarin therapy. Ann Intern Med 111:730–7PubMed White RH, McCurdy SA, Von Marensdorff H, Woodruff DE, Leftgoff L (1989) Home prothrombin time monitoring after initiation of warfarin therapy. Ann Intern Med 111:730–7PubMed
2.
go back to reference Anderson D, Harrison L, Hirsh J (1993) Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulation therapy. Arch Intern Med 153:1441–7PubMedCrossRef Anderson D, Harrison L, Hirsh J (1993) Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulation therapy. Arch Intern Med 153:1441–7PubMedCrossRef
3.
go back to reference Beyth RJ, Landfeldt CS (2000) A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. Ann Intern Med 133:687–95PubMed Beyth RJ, Landfeldt CS (2000) A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. Ann Intern Med 133:687–95PubMed
4.
go back to reference Wittkowsky AK, Sekreta CM, Nutescu EA, Ansell J (2005) Barriers to patient self-testing of prothrombin Time: national survey of anticoagulation practitioners. Pharmacotherapy 25(2):265–269PubMedCrossRef Wittkowsky AK, Sekreta CM, Nutescu EA, Ansell J (2005) Barriers to patient self-testing of prothrombin Time: national survey of anticoagulation practitioners. Pharmacotherapy 25(2):265–269PubMedCrossRef
Metadata
Title
Patient barriers and solutions for INR self-testing
Author
Nancy L. Shapiro
Publication date
01-02-2008
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 1/2008
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-007-0100-2

Other articles of this Issue 1/2008

Journal of Thrombosis and Thrombolysis 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.